1
You're invited to the Novo Nordisk satellite symposium: Symposium recording available on-demand, within the virtual platform, following the conclusion of the congress The Apis bull logo is a registered trademark of Novo Nordisk A/S. 2020 © Novo Nordisk A/S, Novo Allé, DK-2880, Bagsværd, Denmark An interactive scientific symposium supported by Novo Nordisk. 02 February 2021 · 18.00 -19.00 CET Making treatment choices in the present and future of haemophilia care Interactive clinical case discussions Introduction 5 minutes 45 minutes Q&A 10 minutes Dr Maria Elisa Mancuso Humanitas Research Hospital Italy Dr Pratima Chowdary Royal Free Hospital UK Dr Cedric Hermans St-Luc University Hospital Belgium ANTHONY ROBERTS Anthony has Haemophilia A South Africa GARY BUSHELL Gary has Haemophilia B with inhibitors UK BENJAMIN DAVIS Benjamin has Haemophilia A with inhibitors USA How to better tailor treatments to individual patients? This symposium will focus on optimising treatment across the spectrum of ever-changing patient needs. The expert panel of speakers will discuss current and future therapies as they share their approaches to clinical-decision making. 2021 European Association for Haemophilia and Allied Disorders
